Table 2: Clinical data in male patients according to SUA quartile.

ParameterQ1 groupQ2 groupQ3 groupQ4 groupP value
(SUA≤295)(347≥SUA≥296)(406≥SUA≥348)(SUA≥407)

n124116119119
Age (years)75.08 ± 4.6775.5 ± 4.5375.44 ± 3.9075.92 ± 4.610.917
SBP (mmHg)134.13 ± 15.94133.43 ± 13.56137.22 ± 20.82135.22 ± 14.360.309
DBP (mmHg)79.52 ± 8.8479.81 ± 8.3780.21 ± 8.1180.16 ± 7.440.378
WC (cm)85.25 ± 8.0386.06 ± 8.4687.73 ± 8.2787.97 ± 9.410.037
WHR0.89 ± 0.050.91 ± 0.050.92 ± 0.060.92 ± 0.070.003
BMI (kg/m2)24.24 ± 3.0724.34 ± 2.8125.08 ± 3.1225.35 ± 3.100.009
FBG (mmol/L)8.79 ± 3.107.79 ± 2.787.50 ± 1.737.43 ± 1.59<0.001
HbA1c(%)7.69 ± 2.247.36 ± 1.896.99 ± 1.336.92 ± 1.17<0.001
TC (mmol/L)4.67 ± 0.864.66 ± 0.954.58 ± 1.054.79 ± 0.890.382
TG (mmol/L)1.27 ± 0.621.53 ± 1.071.50 ± 0.651.97 ± 1.08<0.001
LDL-C (mmol/L)2.78 ± 0.632.76 ± 0.652.68 ± 0.822.83 ± 0.650.426
HDL-C (mmol/L)1.27 ± 0.271.21 ± 0.251.19 ± 0.291.13 ± 0.19<0.001
eGFR (ml/min/1.73m2)89.95 ± 8.0188.80 ± 9.3282.51 ± 10.4778.70 ± 12.72<0.001
leukocyte (x109/L)6.17 ± 1.576.04 ± 1.406.47 ± 1.556.39 ± 1.570.105
Hb(g/L)143.31 ± 13.12145.11 ± 15.22144.40 ± 12.61145.24 ± 13.240.674
SUA(μmol/L)258.71 ± 27.45322.25 ± 15.66376.76 ± 17.83456.53 ± 57.28<0.001
Urine pH5.98 ± 0.855.73 ± 0.675.68 ± 0.765.61 ± 0.690.001
UACR10.73 ± 7.039.06 ± 6.699.08 ± 6.7110.37 ± 8.130.154

Compared with Q1 group, P<0.05; compared with Q2 group, P<0.05; compared with Q3 group, #P<0.05; systolic blood pressure (SBP), diastolic blood pressure (DBP), waist circumference (WC), waist-to-hip ratio (WHR), body mass index (BMI), fasting blood glucose (FBG), glycated hemoglobin (HbA1c), triglyceride (TG), total cholesterol (TC), low density lipoprotein-cholesterol (LDL-C), high density lipoprotein-cholesterol (HDL-C), hemoglobin (Hb), serum uric acid (SUA), and urinary albumin creatinine ratio (UACR).